Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patients undergoing PRK surgery for corneal wound repair after refractive surgery. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Kiora Pharmaceuticals Inc..
Kiora Pharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Kiora Pharmaceuticals Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Kiora Pharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Kiora Pharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Kiora Pharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of Kiora Pharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Kiora Pharmaceuticals Inc.- Key Facts
2.2 Kiora Pharmaceuticals Inc.- Geographic Locations
2.3 Kiora Pharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 Kiora Pharmaceuticals Inc.- Business Divisions
2.5 Kiora Pharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Kiora Pharmaceuticals Inc. Strategic Analysis Review
3.1 Kiora Pharmaceuticals Inc.- Key Strategies
3.2 Kiora Pharmaceuticals Inc.- Company Outlook Statement
3.3 Kiora Pharmaceuticals Inc.- SWOT Analysis
3.3.1 Kiora Pharmaceuticals Inc.- Key Strengths
3.3.2 Kiora Pharmaceuticals Inc.- Key Weaknesses
3.3.3 Kiora Pharmaceuticals Inc.- Potential Opportunities
3.3.4 Kiora Pharmaceuticals Inc.- Potential Threats
3.4 Kiora Pharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 Kiora Pharmaceuticals Inc.- Business Overview
4.2 Kiora Pharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 Kiora Pharmaceuticals Inc.- Key Products
5.2 Kiora Pharmaceuticals Inc.- Key Service Areas
5.3 Kiora Pharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 Kiora Pharmaceuticals Inc.- Company History
6.2 Kiora Pharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 Kiora Pharmaceuticals Inc.- Income Statements
7.2 Kiora Pharmaceuticals Inc.- Balance Sheet
7.3 Kiora Pharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Kiora Pharmaceuticals Inc.- Direct Competitors
8.2 Kiora Pharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 Kiora Pharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 Kiora Pharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
